Amgen Inc.
Long

Pioneering Human Therapeutics $AMGN

55
Amgen, Inc. is a biotechnology company that specializes in the discovery, development, manufacture, and marketing of human therapeutics. Founded on April 8, 1980, by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld, the company is headquartered in Thousand Oaks, CA.

Notable Products and Research Areas

Amgen, Inc. has developed several notable products, including:

-Enbrel (etanercept), a treatment for rheumatoid arthritis and psoriatic arthritis
- Neulasta (pegfilgrastim), a medication for preventing chemotherapy-induced neutropenia
- Prolia (denosumab), a treatment for osteoporosis

The company also conducts research in various areas, including:

-Cancer treatment and therapy
-Cardiovascular disease
-Neurology and neuroscience
-Inflammation and immunology

Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.